News
Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to ...
The school year just started, and some students are already busy in a new state-of-the-art space, all made possible by a $2.8 ...
The new exhibit is available at the North End Event Center, and includes all kinds of space-oriented attractions.
4d
ExtremeTech on MSNGene Therapy Could Let Future Implants Control the Brain Via Ultrasound
One of Sam Altman’s pet projects aims to engineer the brain to better work with brain-computer interface implants.
Elon Musk and Sam Altman speak onstage at the Vanity Fair New Establishment Summit on October 6, 2015 in San Francisco, ...
Hyderabad: In a restructuring exercise, Laurus Labs is demerging Unit-1, which is the API manufacturing component of its ...
7hon MSN
Ultrack and inTRACKtive: A powerful pair of tools to help track cells through embryonic development
With today's advanced microscopes, scientists can capture videos of entire embryos developing in real time. But there's a ...
The frontier of human-machine integration is witnessing a significant strategic shift as Sam Altman, the prominent CEO of ...
1d
Cryptopolitan on MSNLayerZero wins Stargate takeover with 94% DAO approval in rare $120 million deal
Cross-chain protocol LayerZero has announced the acquisition of multichain bridge Stargate Finance for $120 million worth of ...
Aptorum stock rises after DiamiR Biosciences secures New York approval for its APOE Genotyping test ahead of a planned merger.
In just three years, Abhishek Jagtap, Founder & CEO of CodeSquare Labs, has emerged as one of the most recognized young names ...
Aptorum Group Limited (NASDAQ: APM) shares dropped 33.18% in Friday's pre-market trading after soaring 234.65% the previous session, driven by DiamiR's test approval and merger news, with trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results